Weiss Asset Management LP Ani Pharmaceuticals Inc Transaction History

Weiss Asset Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $3.04 Million - $4.02 Million	-47,054 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $2.2 Million - $2.67 Million	-32,517 Reduced 40.87%	47,054 $3.87 Million
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $1.29 Million - $1.99 Million	-28,200 Reduced 26.17%	79,571 $5.61 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $3.1 Million - $4.24 Million	75,206 Added 230.94%	107,771 $4.85 Million
Q3 2018 Nov 13, 2018	BUY	$52.95 - $71.34 $1.72 Million - $2.32 Million	32,565 New	32,565 $1.84 Million

Q1 2018 May 15, 2018	SELL	$56.98 - $72.41 $663,190 - $842,779	-11,639 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $7.65 Million - $10.7 Million	-143,450 Reduced 92.5%	11,639 $750,000
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $6.74 Million - $8.14 Million	155,089	155,089 $8.14 Million

206

14M

26.7K

237K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.07B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.